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This study describes a comparative analysis of the Beijing mycobacterial interspersed repetitive unit types
of Mycobacterium tuberculosis isolates from Cape Town, South Africa, and East Asia. The results show a
significant association between the frequency of occurrence of strains from defined Beijing sublineages and the
human population from whom they were cultured (P < 0.0001).
Mycobacterium tuberculosis strains with the Beijing genotype
have been shown to be globally widespread and are particularly
prevalent in East Asia, where over 80% of strains from the
Beijing, China, region are of this genotype (5). It has been
hypothesized that Beijing strains have evolved unique proper-
ties, including the ability to evade the protective effect of My-
cobacterium bovis BCG vaccination (19) and the ability to
spread more efficiently than non-Beijing strains (2). However,
the clinical presentations of patients with tuberculosis caused
by a Beijing strain were found to vary between different geo-
graphical settings (3–5,16). Currently, it is not known whether
the observed variability in clinical presentation is a function of
the Beijing strain population found in particular geographical
settings, is a function of the genetic composition of the human
population, or is a function of a combination of these two
variables.
This study aimed to test the hypothesis that host-pathogen
compatibility determined the Beijing strain population struc-
ture in different host populations in different geographical
settings. Cultures of M. tuberculosis isolates from patients of
mixed ancestry (14) who were resident in Cape Town, South
Africa (20), were classified as being of the Beijing genotype by
spoligotyping (10). The Beijing strains were assigned to phy-
logenetic sublineages as described previously (8) and were
genotyped by mycobacterial interspersed repetitive unit
(MIRU) typing (17).
During the study period (January 1993 to December 2004),
25 MIRU types were identified among 321 tuberculosis cases
infected with a Beijing strain (Table 1). A comparison of the
MIRU type data for the Beijing strains from Cape Town and
previously published MIRU type data for the Beijing strains
from East Asia (1, 9, 12, 13, 15, 18) showed that nine of the
Beijing MIRU types (types MT01, MT08, MT11, MT18,
MT19, MT21, MT28, MT33, and MT54) were shared between
these geographical settings (Table 1). This suggests that the
nine shared Beijing MIRU types represent founder strains that
were introduced into Cape Town from East Asia, as the latter
is thought to be the evolutionary origin of strains with a Beijing
genotype (5, 7, 12). The definition of founder MIRU types was
supported by their disproportionately high number (n  267)
compared to the number with nonfounder MIRU types (n 
54) in tuberculosis patients from Cape Town (z test for the
hypothesis that the proportion of types were founder MIRU
types  0.5; P  0.001).
Superimposition of the Beijing MIRU type data onto the
previously described phylogenetic tree of the Beijing strain
family (8) provided a framework that could be used to predict
the evolutionary order in which the 25 Beijing MIRU types had
evolved (Fig. 1). From this prediction, the Beijing MIRU types
could be partitioned into seven Beijing sublineages. The num-
ber of founder Beijing MIRU types was variable among the
different Beijing sublineages (Fig. 1). Twenty-four of the Bei-
jing MIRU types were unique to their respective sublineages,
while the remaining Beijing MIRU type (MT11) was shared by
three different sublineages (sublineages 2, 3, and 6) (Fig. 1 and
Table 1), suggesting that MT11 was an ancestral Beijing MIRU
type (12).
To determine the propensity of Beijing strains from the
different sublineages to spread in the human population in
Cape Town, the number of cases in circulation within each
sublineage was compared to the number of founder strains for
that sublineage (Table 1). The number of representatives of
these founder strains was shown to be overrepresented in sub-
lineage 7 (n  233 cases from one founder strain) compared
with the numbers in sublineages 1 to 6 (n 88 cases from eight
founder strains) (z test for the hypothesis that the proportion
of sublineage 7 cases  0.11; P  0.001). In comparison,
founder Beijing MIRU types MT01, MT08, MT11, MT18,
MT19, MT21, MT33, and MT54 were overrepresented in the
human population in East Asia (China, 73/130; Hong Kong,
108/211; Vietnam, 25/37; and Singapore, 45/56) compared to
their representation in Cape Town, South Africa (79/321)
(Fisher’s exact test odds ratio [OR], 4.20; 95% confidence
interval [CI], 3.06 to 5.77; P  0.0001).
A significant association between the frequency of occur-
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rence of strains of defined Beijing sublineages and the human
population from whom they were isolated was observed (for
sublineages 1 to 6, n 88 for Cape Town and n 253 for East
Asia; for sublineage 7, n  233 for Cape Town and n  43 for
East Asia; Fisher’s exact test OR, 15.58; 95% CI, 10.38 to
23.38; P  0.0001).
It is unlikely that these findings can be explained by multiple
importations of founder strains of sublineage 7 in preference
TABLE 1. Geographical distribution of Beijing MIRU types from Asia and South Africa
MIRU type Beijingsublineage(s)b
No. of copies in the following polymorphic MIRU loci: No. (%) of strains fromh:
2 4 10 16 20 23 24 26 27 31 39 40 RUSc,d CHNd HKe VNMd SGPf BGDg CT-SA
MT01a 4 2 2 3 3 2 5 1 7 3 4 3 3 1 (2.2) 5 (3.8) 7 (3.3) 2 (16.7) 1 (0.3)
MT02 NAi 2 2 3 3 2 5 1 5 3 5 3 3 27 (60.0) 2 (1.5) 4 (1.9) 2 (3.6) 7 (58.3)
MT04 NA 2 2 3 2 2 5 1 5 3 5 3 3 1 (2.2) 1 (2.7)
MT05 NA 2 2 3 3 2 5 1 4 3 5 3 3 1 (2.2)
MT07 NA 2 2 3 3 2 5 1 5 3 6 3 3 2 (4.4)
MT08a 6 2 2 3 2 2 5 1 7 3 5 3 3 1 (2.2) 2 (1.5) 3 (1.4) 2 (0.6)
MT09 NA 2 2 3 3 2 5 1 7 3 5 3 1 1 (2.2) 1 (2.7)
MT11a 2, 3, 6 2 2 3 3 2 5 1 7 3 5 3 3 10 (22.2) 42 (32.3) 77 (36.5) 10 (27.0) 39 (69.6) 3 (0.9), 2 (0.6),
8(2.5)j
MT12 NA 2 2 1 3 2 5 1 7 3 5 3 3 1 (2.2) 1 (0.8)
MT13 NA 2 2 3 3 2 6 1 7 1 5 3 1 8 (3.8) 1 (2.7)
MT14 NA 2 2 3 3 2 5 1 7 3 6 3 3 2 (1.5) 3 (1.4) 1 (2.7) 2 (3.6)
MT16 NA 2 2 3 3 2 5 1 7 3 5 3 2 5 (3.8) 12 (5.7) 5 (8.9)
MT17 NA 2 2 3 4 2 5 1 7 3 5 3 3 1 (0.8) 1 (1.8)
MT18a 6 2 2 3 3 2 5 1 7 3 5 4 3 2 (1.5) 5 (2.4) 2 (3.6) 7 (2.2)
MT19a 5 2 0 3 3 2 5 1 7 3 5 3 3 2 (0.9) 1 (2.7) 39 (12.1)
MT20 7 2 2 2 3 2 5 1 7 4 5 4 3 19 (5.9)
MT21a 6 2 2 3 3 2 5 1 8 3 5 3 3 4 (3.1) 6 (2.8) 2 (5.7) 4 (7.1) 13 (4.0)
MT25 7 2 2 2 3 2 5 1 7 3 3 4 3 18 (5.6)
MT26 6 2 2 3 3 2 5 1 7 3 5 4 4 1 (0.3)
MT27 7 2 2 2 3 2 5 1 3 3 5 4 3 1 (0.3)
MT28a 7 2 2 2 3 2 5 1 7 3 5 4 3 16 (12.3) 23 (10.9) 4 (10.8) 189 (58.9)
MT29 6 2 2 3 3 2 5 1 7 4 5 3 3 1 (0.3)
MT33a 6 NA 2 3 3 NA NA NA 6 3 5 3 3 11 (8.5) 4 (1.9) 12 (32.4) 3 (0.9)
MT37 NA NA 2 3 3 NA NA NA 2 3 5 3 3 2 (1.5) 1 (8.3)
MT43 NA NA 2 3 3 NA NA NA 6 3 4 3 3 2 (16.7)
MT44 NA NA 2 2 3 NA NA 7 3 5 3 3 6 (4.6) 9 (4.3) 1 (2.7)
MT47 NA NA 2 3 3 NA NA NA 7 1 5 3 1 3 (2.3) 6 (2.8) 3 (8.1)
MT48 NA NA 2 3 3 NA NA NA 4 3 4 3 3 2 (1.5)
MT49 NA NA 2 7 2 NA NA NA 7 3 4 3 3 3 (2.3)
MT50 NA NA 2 5 2 NA NA NA 7 3 4 3 3 2 (1.5)
MT51 NA NA 2 3 2 NA NA NA 5 1 5 3 3 2 (1.5)
MT52 NA NA 2 3 3 NA NA NA 6 3 5 3 2 2 (1.5)
MT53 NA NA 2 3 3 NA NA NA 7 3 5 1 3 2 (1.5)
MT54a 6 NA 2 3 3 NA NA NA 7 3 5 2 3 7 (5.4) 4 (1.9) 1 (0.3)
MT55 NA NA 2 2 3 NA NA NA 5 3 3 4 3 2 (1.5)
MT56 NA NA 2 2 3 NA NA NA 9 3 5 4 3 2 (1.5)
MT57 NA NA 2 2 3 NA NA NA 7 3 5 2 3 2 (1.5)
MTSGP76 NA 2 2 6 2 2 5 1 7 3 4 3 3 1 (1.8)
MTCT-SA1 1 2 2 3 3 2 5 1 6 3 5 3 1 1 (0.3)
MTCT-SA2 5 2 3 3 3 2 5 1 7 3 5 3 3 1 (0.3)
MTCT-SA3 6 2 2 3 3 2 5 1 7 2 5 3 3 3 (0.9)
MTCT-SA4 6 2 2 3 3 2 5 1 5 3 5 3 3 1 (0.3)
MTCT-SA5 6 2 2 4 3 2 6 1 5 3 3 2 3 1 (0.3)
MTCT-SA6 7 2 2 2 3 2 5 1 7 4 4 4 3 1 (0.3)
MTCT-SA7 7 2 2 2 3 2 5 1 8 4 5 4 3 1 (0.3)
MTCT-SA8 7 2 2 2 3 2 5 1 9 3 5 3 3 1 (0.3)
MTCT-SA9 7 2 2 2 3 2 5 1 7 3 4 4 3 1 (0.3)
MTCT-SA10 7 2 2 2 3 2 5 1 5 3 5 4 3 1 (0.3)
MTCT-SA11 7 2 2 4 3 2 5 1 5 3 3 2 3 1 (0.3)
MTHK1 NA 2 2 3 3 2 5 1 7 3 5 3 4 6 (2.8)
MTHK2 NA 2 2 3 3 2 5 1 7 3 5 5 3 5 (2.4)
MTHK3 NA 2 2 3 4 2 5 1 7 3 5 3 2 5 (2.4)
MTHK4 NA 2 1 3 3 2 5 1 7 3 5 3 3 4 (1.9)
MTHK5 NA 2 2 3 3 2 5 1 6 3 5 3 4 3 (1.4)
MTHK6 NA 2 0 3 3 2 5 1 7 3 5 3 4 3 (1.4)
MTHK7 NA 2 2 3 3 2 5 1 7 3 5 4 2 2 (0.9)
MTHK8 NA 2 2 3 3 2 5 1 8 3 5 5 3 2 (0.9)
MTHK9 NA 2 2 2 3 2 5 1 7 3 5 3 2 2 (0.9)
MTHK10 NA 2 2 3 3 2 5 1 6 3 7 3 3 2 (0.9)
MTHK11 NA 2 2 3 3 2 2 1 7 4 4 3 3 2 (0.9)
MTHK12 NA 2 2 2 3 2 5 1 7 3 5 4 4 2 (0.9)
a Founder MIRU types.
b According to reference 8.
c According to reference 13.
d According to reference 12.
e According to reference 9.
f According to reference 15.
g According to reference 1.
h RUS, Russia; CHN, China; HK, Hong Kong; VNM, Vietnam; SGP, Singapore; BGD, Bangladesh; CT-SA, Cape Town, South Africa.
i NA, not available.
j Data are for sublineages 2, 3, and 6, respectively.
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to founder strains of sublineages 1 to 6, given that immigrants
to South Africa came from many different geographical regions
in East Asia and that sublineage 7 founder strains are less
frequently observed in East Asia. Accordingly, we propose that
the situation in Cape Town represents an approximation to a
common starting point for all the founder strains introduced,
with those best adapted to the local population spreading most
efficiently. This could be due to the innate characteristics of the
strains within defined Beijing sublineages or the local host
population. Susceptibility to M. tuberculosis per se has fre-
quently been associated with the HLA genotype (11), and
HLA allele frequencies are known to differ widely between
human populations with different histories, with certain alleles
totally absent in some populations. Our conclusion differs from
FIG. 1. Evolutionary scenario of Beijing MIRU types according to Beijing sublineage. Beijing MIRU types were grouped according to their
respective Beijing sublineages (8), and the most parsimonious evolutionary order was proposed. The Beijing MIRU types are indicated within each
box. Founder Beijing MIRU types are indicated by bold boxes. Unknown Beijing MIRU types are indicated by “?.”
VOL. 45, 2007 NOTES 2265
that of Gagneux et al. (6), as we demonstrate that strains from
a defined sublineage (a subset of strains from an evolutionary
lineage) may have been selected by a human population in a
defined geographical setting.
In summary, the global success of the Beijing lineage may
reflect either the selection of defined sublineages in different
geographical settings by distinct human populations or the
adaptation of strains in a defined sublineage to spread more
readily in a distinct human population. We acknowledge that
these contrasting conclusions cannot be easily distinguished
with the available data. However, the emergence of a sub-
lineage of Beijing strains with increased pathogenicity may
have important implications for the Tuberculosis Control Pro-
gram. Early diagnosis and contact tracing will be essential to
curb the spread of these strains. Furthermore, it will be im-
portant to ensure that future vaccines protect against these
strains.
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AUTHOR’S CORRECTION
Evidence that the Spread of Mycobacterium tuberculosis Strains with the Beijing
Genotype Is Human Population Dependent
M. Hanekom, G. D. van der Spuy, N. C. Gey van Pittius, C. R. E. McEvoy, S. L. Ndabambi,
T. C. Victor, E. G. Hoal, P. D. van Helden, and R. M. Warren
DST/NRF Centre of Excellence for Biomedical Tuberculosis Research/MRC Centre for Molecular and Cellular Biology, Division of
Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa
Volume 45, no. 7, p. 2263–2266, 2007. Pages 2264 and 2265: The MIRU patterns 224326153323 and 224325153323, associated
with the Mycobacterium tuberculosis strains represented by MIRU types MTCT-SA5 and MTCT-SA11, respectively, in Table 1 and
shown as members of sublineages 6 and 7, respectively, in Fig. 1 are not representative of the Beijing genotype but correspond to
the LAM3 genotype and the T1 genotype, respectively. Exclusion of these isolates does not significantly alter the statistical analysis.
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